• menu

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    Coral
    |
    Weekly News Recap #Phispers
    FDA approves Wegovy to reduce cardiovascular risks; delays action on Lilly’s Alzheimer’s drug

    FDA approves Wegovy to reduce cardiovascular risks; delays action on Lilly’s Alzheimer’s drug

    In this week’s news, Novo Nordisk’s Wegovy became the first obesity drug cleared by the US Food and Drug Administra...

    Impressions : 2542

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.